Complete Clinical Guide to Hiv Skin Rashes: Identification, Testing, and Care
By Alexander Ross
As HIV progresses beyond the acute window into clinical latency, the immune architecture within the skin steadily degrades. Langerhans cells and CD4+ T-cells dwindle, blunting the skin's defense against common microbes.
Pruritic papular eruption represents one of the most common dermatological markers of worsening immune health in untreated patients. Characterized by itchy, firm bumps scattered across the forearms, lower legs, and torso, PPE often leaves lingering dark scars from repeated scratching. While acute seroconversion rashes fade quickly, PPE persists for months unless the patient starts antiretroviral therapy.
Seborrheic dermatitis also takes a distinctive, aggressive form in people with unmanaged HIV. In an immunocompetent person, this yeast-driven condition causes mild dandruff or faint redness along the nostrils. In an immunocompromised host, it can turn into an inflamed, crusty mask covering the face, ears, and chest.
In late-stage disease, Kaposi sarcoma remains the most serious cutaneous manifestation. Driven by human herpesvirus-8 (HHV-8), these malignant endothelial tumors present as dark red, purple, or brown patches that do not pale when pressed. They can appear anywhere on the skin, oral palate, or lungs, requiring immediate oncological and antiretroviral care.
Alexander Ross has covered the video game industry for a decade, writing deep dives on game design, esports tournaments, VR developments, and gaming culture.
